Tech Company Financing Transactions
Solid Immuno-Oncology Funding Round
Solid Immuno-Oncology secured a $830 thousand financing round on 2/24/2025. Investors included Nordic Science Investments, BSV Ventures and private investors.
Transaction Overview
Company Name
Announced On
2/24/2025
Transaction Type
Venture Equity
Amount
$830,000
Round
Undisclosed
Investors
Proceeds Purpose
The funds will primarily go toward planning and executing clinical trials, building Solid IO's regulatory strategy, and preparing for US market entry.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
C/O Terkko Health Hub Haartmaninkatu 4, building 14
Helsinki, 00290
Finland
Helsinki, 00290
Finland
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
At Solid IO, we combine deep scientific expertise with real-world clinical impact. Our team is pioneering patient-specific organ-on-chip technology to transform cancer care. By bridging the gap between research and treatment, we turn biological complexity into clear, actionable insights. The result? Smarter decisions, more precise therapies, and a future where personalized medicine isn't just possible -- it's standard.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Noora Hujala
Browse more venture capital transactions:
Prev: 2/24/2025: WilsonAI venture capital transaction
Next: 2/24/2025: Genspark venture capital transaction
Share this article
Where The Data Comes From
We report on tech company VC transactions. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs